Royal Society of Chemistry, RSC Medicinal Chemistry, 3(14), p. 444-453, 2023
DOI: 10.1039/d2md00360k
Full text: Unavailable
By screening a library of 18F-labeled tetrazines, we identified tetrazines which showed high pretargeted PET imaging contrast beyond the blood–brain-barrier.